Kaiser Permanente has commissioned a study to evaluate the effectiveness of the mRNA vaccine against the dominant omicron subvariants.
- The efficacy continues to fall in the following months then reaches negative territory after five months, meaning the recipient is more likely to get COVID than if he or she had not been vaccinated
- Supporters of continued vaccination argue that this is the reason for the new bivalent shot for the BA.5 variant that was approved after it was studied on eight mice and no humans
- A new variant is surging, making the new shot as irrelevant as the previous ones and likely counterproductive
https://www.wnd.com/2022/10/insurance-company-finds-triple-vaxxed-likely-get-covid-unvaxxed/
No comments:
Post a Comment